ArticleHeliyon2024

Response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis with the N1303K mutation: Case report and review of the literature.

Maria G Tupayachi Ortiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.